Ciloa has developed strong partnership with leading experts and academic communities in the field. This key aspect of Ciloa strategy is the basis for its innovative offer.
A MODEL BASED ON PARTNERSHIPS
ACADEMIC AND SCIENTIFIC PARTNERSHIPS
TECHNOLOGY LICENCING
SOME OF OUR PARTNERS
PARTNERSHIPS
- Leading Biotech (Confidential, USA) : Out-licencing
- CNRS (Dr Jaffredo)
- NEURATRIS
- INSERM (Dr Guillaume Van Niel) : Exosomes / Zebra fish model
- UMR U1187 INSERM, CYROI, La réunion (Pr. P. Despres)
- NIH, Scripps Institute, CA, USA
- International AIDS Vaccine Initiative, New York, USA
- UMR 9004/CNRS/UM : Exosomes Pathway
- INSERM, UMR S 1072 / CNRS, UMR 7286 (Dr. O. El Far, C. Levêque)
- DIMNP, UMR 5235 CNRS-UM, Montpellier (Drs. M. Lebrun, M. Vidal)
FINANCIAL PARTNERSHIPS
- CkikVax : this project is supported by FEDER (Fond européen de développement régional). The aim of this project is to develop novative vaccine (virus & adjuvant free) against Chikungunya.
- PASS EXPORT (Région Occitanie) : International Development
All thanks to :
Dr. Graça Raposo – Institut Curie / CNRS UMR 144, Paris, France
Dr. Isabelle Dimier-Poisson – UMR Université-INRA 0483, Tours, France
for their beautiful electron microphotographs of exosomes.